AI assistant
GlaxoSmithkline Pharmaceuticals Ltd. — Regulatory Filings 2024
Jan 25, 2024
60440_rns_2024-01-25_c1938a0a-40c4-4950-9df5-ede0995dfda9.pdf
Regulatory Filings
Open in viewerOpens in your device viewer
==> picture [129 x 40] intentionally omitted <==
GlaxoSmithKline Pharmaceuticals Limited GSK House, Dr. Annie Besant Road, Worli, Mumbai - 400 030 Tel No: +91 22 2495 9595 Fax No: +91 22 2495 9494 Web: www.gsk-india.com Email: [email protected]
25[th] January 2023
To,
BSE LIMITED
Phiroze Jeejeebhoy Towers Dalal Street Mumbai - 400001
THE NATIONAL STOCK EXCHANGE OF INDIA LIMITED
Exchange Plaza, 5[th] Floor, Plot No. C/1, G Block Bandra-Kurla Complex, Bandra (East) Mumbai - 400051
Dear Sir,
Subject: Advance intimation under regulation 39(3) as SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Pursuant to Regulation 39 and other application regulations of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the "Regulations"), we would like to inform you that Registrar and Transfer Agent of Company M/s. KFin Technologies Limited has received below mentioned request for issue of duplicate Share Certificates from Shareholder.
| Slno | Folio | Name | Certificate No. | Shares | Dist From | Dist To |
|---|---|---|---|---|---|---|
| 1 | 0312542 | DORMI INVESTMENTS (P) LTD | 1141942 | 37 | 78365402 | 78365438 |
| 1294096 | 37 | 171895193 | 171895229 | |||
| DAKSHA MAHESH GANDHI | 67536961 | |||||
| 2 | 0304210 | MAHESH DHIRAJLAL GANDHI | 1136358 | 47 | 67536915 |
We shall issue the Letter of Confirmation only after the necessary formalities are carried out by the Shareholder.
Thanking you,
Yours faithfully
For GlaxoSmithKline Pharmaceuticals Limited
Digitally signed by Ajay Ajay Avinash Avinash Nadkarni Nadkarni Date: 2024.01.25 10:02:37 +05'30' Ajay Nadkarni Vice President – Administration, Real Estate & Company Secretary
CIN: L24239MH1924PLC001151